EUVIMEDEUVIMED entdecken
Crossref

Efficient application of Pyrosin B for nano‐gram level assay of antiparkinsonian medication, rasagiline: Evaluation of tablets and content uniformity

Ahmed A Abu-Hassan iD, Wael A Mahdi, Sultan Alshehri, Mohamed A El Hamd iD

Luminescence · 2024

DOI: 10.1002/bio.4853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2024. Verfasst von Ahmed A Abu-Hassan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt. Hauptthemen laut MEDLINE: Indans, Tablets, Antiparkinson Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: King Saud University, Shaqra University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rasagiline (RAS) is a medication for Parkinson's disease that increases dopamine levels in the brain by inhibiting monoamine oxidase, helping to alleviate symptoms. The proposed study aims to develop an efficient, feasible, and sensitive method for RAS assay, utilizing Pyrosin B dye, a convenient fluorescent ligand. Combining the RAS analyte with Pyrosin B ligand in a mildly acidic buffered solution rapidly quenches the native fluorescence of the ligand. This quenching results from the formation of a specific ion‐dipole association complex between the lone pair‐bearing atoms of the ligand and the protonated amine moiety of RAS, highlighting their interactive chemistry under these conditions. The degree of this interaction demonstrated superior sensitivity compared with reported alternatives, exhibiting a linear range of 50.0 to 1000.0 ng/mL. The method is characterized by a limit of detection (LOD) of 16.0 ng/mL and a limit of quantification (LOQ) of 48.0 ng/mL. By optimizing the RAS‐Pyrosin B system, the variable parameters were finely tuned, ensuring the assay method's reliability. The method's accuracy, precision, selectivity, and robustness were validated according to International Council for Harmonization (ICH) guidelines, enabling precise and efficient analysis of RAS in the nanogram range. This method streamlines the analysis procedure and reduces environmental impact, making it a promising approach for the quality control of Parkintreat R tablets (1 mg) and other analytical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndansTabletsAntiparkinson AgentsLimit of DetectionMolecular StructureFluorescent DyesSpectrometry, Fluorescence

Stichwörter der Autor:innen

ParkintreatR tablets (1 mg)Pyrosin Bantiparkinsonian medicamentcontent uniformityrasagiline

Substanzen

rasagilineIndansTabletsAntiparkinson AgentsFluorescent Dyes

Autor:innen und Institutionen

  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia.
  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena, Egypt.

ORCID-Profile: Ahmed A Abu-Hassan, Mohamed A El Hamd

Förderung

  • King Saud University
  • Shaqra University

Zitieren

APA

Abu-Hassan, A. A., Mahdi, W. A., Alshehri, S., & El Hamd, M. A. (2024). Efficient application of Pyrosin B for nano‐gram level assay of antiparkinsonian medication, rasagiline: Evaluation of tablets and content uniformity. Luminescence. https://doi.org/10.1002/bio.4853

Vancouver

Abu-Hassan AA, Mahdi WA, Alshehri S, El Hamd MA. Efficient application of Pyrosin B for nano‐gram level assay of antiparkinsonian medication, rasagiline: Evaluation of tablets and content uniformity. Luminescence. 2024. doi:10.1002/bio.4853

BibTeX
@article{AbuHassan2024,
  author = {Abu-Hassan, Ahmed A and Mahdi, Wael A and Alshehri, Sultan and El Hamd, Mohamed A},
  title = {Efficient application of Pyrosin B for nano‐gram level assay of antiparkinsonian medication, rasagiline: Evaluation of tablets and content uniformity},
  journal = {Luminescence},
  year = {2024},
  doi = {10.1002/bio.4853}
}
Kostenlos starten →